Mackenzie R Wehner1, Wilmarie Cidre Serrano2, Adi Nosrati3, Patrick Michael Schoen4, Mary-Margaret Chren3, John Boscardin5, Eleni Linos6. 1. Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. 2. Harvard Medical School, Boston, Massachusetts; Department of Psychiatry, Stanford University, Stanford, California. 3. Dermatology Service, Veterans Affairs Medical Center, San Francisco, California; Department of Dermatology, University of California, San Francisco, California. 4. Department of Dermatology, University of California, San Francisco, California. 5. Department of Epidemiology and Biostatistics, University of California, San Francisco, California. 6. Department of Dermatology, University of California, San Francisco, California. Electronic address: LinosE@derm.ucsf.edu.
Abstract
BACKGROUND: There are varying reports of the association of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) with mortality. OBJECTIVE: To synthesize the available information on all-cause mortality after a diagnosis of BCC or SCC in the general population. METHODS: We searched PubMed (1966-present), Web of Science (1898-present), and Embase (1947-present) and hand-searched to identify additional records. All English articles that reported all-cause mortality in patients with BCC or SCC were eligible. We excluded case reports, case series, and studies in subpopulations of patients. Random effects model meta-analyses were performed separately for BCC and SCC. RESULTS: The searches yielded 6538 articles, and 156 were assessed in a full-text review. Twelve studies met the inclusion criteria, and 4 were included in the meta-analysis (encompassing 464,230 patients with BCC and with 175,849 SCC), yielding summary relative mortalities of 0.92 (95% confidence interval, 0.83-1.02) in BCC and 1.25 (95% confidence interval, 1.17-1.32) in SCC. LIMITATIONS: Only a minority of studies controlled for comorbidities. There was significant heterogeneity in meta-analysis (χ2P < .001, I2 > 98%), but studies of SCC were qualitatively concordant: all showed statistically significant increased relative mortality. CONCLUSIONS: We found that patients with SCC are at higher risk for death from any cause compared with the general population.
BACKGROUND: There are varying reports of the association of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (SCC) with mortality. OBJECTIVE: To synthesize the available information on all-cause mortality after a diagnosis of BCC or SCC in the general population. METHODS: We searched PubMed (1966-present), Web of Science (1898-present), and Embase (1947-present) and hand-searched to identify additional records. All English articles that reported all-cause mortality in patients with BCC or SCC were eligible. We excluded case reports, case series, and studies in subpopulations of patients. Random effects model meta-analyses were performed separately for BCC and SCC. RESULTS: The searches yielded 6538 articles, and 156 were assessed in a full-text review. Twelve studies met the inclusion criteria, and 4 were included in the meta-analysis (encompassing 464,230 patients with BCC and with 175,849 SCC), yielding summary relative mortalities of 0.92 (95% confidence interval, 0.83-1.02) in BCC and 1.25 (95% confidence interval, 1.17-1.32) in SCC. LIMITATIONS: Only a minority of studies controlled for comorbidities. There was significant heterogeneity in meta-analysis (χ2P < .001, I2 > 98%), but studies of SCC were qualitatively concordant: all showed statistically significant increased relative mortality. CONCLUSIONS: We found that patients with SCC are at higher risk for death from any cause compared with the general population.
Authors: Karen Lostritto; Leah M Ferrucci; Brenda Cartmel; David J Leffell; Annette M Molinaro; Allen E Bale; Susan T Mayne Journal: BMC Public Health Date: 2012-02-10 Impact factor: 3.295
Authors: Fengju Song; Abrar A Qureshi; Edward L Giovannucci; Charlie S Fuchs; Wendy Y Chen; Meir J Stampfer; Jiali Han Journal: PLoS Med Date: 2013-04-23 Impact factor: 11.069
Authors: Alexandra Junn; Neha R Shukla; Lily Morrison; Meghan Halley; Mary-Margaret Chren; Louise C Walter; Dominick L Frosch; Dan Matlock; Jeanette S Torres; Eleni Linos Journal: BMC Med Inform Decis Mak Date: 2020-04-29 Impact factor: 2.796
Authors: Stefan A Lange; Jannik Feld; Leonie Kühnemund; Jeanette Köppe; Lena Makowski; Christiane M Engelbertz; Joachim Gerß; Patrik Dröge; Thomas Ruhnke; Christian Günster; Eva Freisinger; Holger Reinecke Journal: Cancers (Basel) Date: 2021-12-09 Impact factor: 6.639